Structure Info
- Chemspace ID
- CSCS00161190091 (Synthesis)
- MFCD
- MFCD31560814
- IUPAC Name
- (1'R,2R,2'S,4'S,5R,7'S,8'R,9'S,12'S,13'S,16'S,18'S)-16'-{[(2R,3R,4R,5R,6R)-3,4-dihydroxy-5-{[(2S,3R,4S,5R,6R)-5-hydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4-{[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]oxy}-6-(hydroxymethyl)oxan-2-yl]oxy}-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-10'-one
- Mol formula
- C50H80O23
- Mol weight
- 1049 Da
- Catalog Number(s)
- 43505, 43505-0.1G, 43505-0.5G, BD00940217, CSC161190091, HY-N5074, M23807, T2S0886, V155810
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- -1.79
- Heavy atoms count
- 73
- Rotatable bond count
- 11
- Number of rings
- 10
- Carbon bond saturation, Fsp3
- 0.98
- Polar surface area (Å)
- 352
- Hydrogen bond acceptors count
- 23
- Hydrogen bond donors count
- 12
- Zoom the structure
- CSCS00161190091
Items Overall 9 items from 4 suppliers
Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
---|---|---|---|---|---|---|
BLD Pharmatech Co., Limited | 30 days | United States To: | 98 | 5 mg | 72 | |
BLD Pharmatech Co., Limited | 30 days | United States To: | 98 | 10 mg | 115 | |
Description: Name:(2aS,4S,5'R,6aS,6bS,8aS,8bR,9S,10R,11aS,12aS,12bR)-4-(((2R,3R,4R,5R,6R)-3,4-Dihydroxy-5-(((2S,3R,4S,5R,6R)-5-hydroxy-6-(hydroxymethyl)-3-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4-(((2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-5',6a,8a,9-tetramethylicosahydrospiro[naphtho[2',1':4,5]indeno[2,1-b]furan-10,2'-pyran]-8(2H)-one; Hazard statement: 6.1; CAS: 179464-23-4 | ||||||
BLD Pharmatech GmbH | 30 days | Germany To: | 98 | 5 mg | 72 | |
BLD Pharmatech GmbH | 30 days | Germany To: | 98 | 10 mg | 115 | |
Description: Name:(2aS,4S,5'R,6aS,6bS,8aS,8bR,9S,10R,11aS,12aS,12bR)-4-(((2R,3R,4R,5R,6R)-3,4-Dihydroxy-5-(((2S,3R,4S,5R,6R)-5-hydroxy-6-(hydroxymethyl)-3-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4-(((2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-5',6a,8a,9-tetramethylicosahydrospiro[naphtho[2',1':4,5]indeno[2,1-b]furan-10,2'-pyran]-8(2H)-one; Hazard statement: 6.1; CAS: 179464-23-4 | ||||||
Astatech CN | 40 days | China To: | 98 | 100 mg | 1,297 | |
Astatech CN | 40 days | China To: | 98 | 500 mg | 3,892 | |
Description: TERRESTROSIN D; CAS: 179464-23-4 | ||||||
Molnova Chemicals | TBD | United States To: | 98 | 5 mg | 107 | |
Molnova Chemicals | TBD | United States To: | 98 | 10 mg | 158 | |
Molnova Chemicals | TBD | United States To: | 98 | 25 mg | 263 | |
Description: Terrestrosin D; CAS: 179464-23-4 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire